

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.72386132 |
| 2 | myelination (GO:0042552) | 7.36767573 |
| 3 | ensheathment of neurons (GO:0007272) | 7.35373562 |
| 4 | axon ensheathment (GO:0008366) | 7.35373562 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.50842325 |
| 6 | activated T cell proliferation (GO:0050798) | 6.41067881 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.28551522 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.84231463 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.80952939 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.78674884 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.78674884 |
| 12 | negative T cell selection (GO:0043383) | 5.72881527 |
| 13 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.60047861 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.48827303 |
| 15 | cholesterol biosynthetic process (GO:0006695) | 5.33416314 |
| 16 | actin-myosin filament sliding (GO:0033275) | 5.32977919 |
| 17 | muscle filament sliding (GO:0030049) | 5.32977919 |
| 18 | negative thymic T cell selection (GO:0045060) | 5.24292420 |
| 19 | positive T cell selection (GO:0043368) | 5.20208858 |
| 20 | oligodendrocyte differentiation (GO:0048709) | 5.10748731 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.07975957 |
| 22 | L-amino acid import (GO:0043092) | 5.05235646 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 5.05204294 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.05165414 |
| 25 | glycerophospholipid catabolic process (GO:0046475) | 5.00400181 |
| 26 | regulation of collateral sprouting (GO:0048670) | 4.91855093 |
| 27 | positive thymic T cell selection (GO:0045059) | 4.91569414 |
| 28 | response to interleukin-15 (GO:0070672) | 4.82458449 |
| 29 | negative regulation of neurotransmitter transport (GO:0051589) | 4.74782757 |
| 30 | response to redox state (GO:0051775) | 4.68423065 |
| 31 | positive regulation of granulocyte differentiation (GO:0030854) | 4.64481316 |
| 32 | sterol biosynthetic process (GO:0016126) | 4.59573918 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 4.53516691 |
| 34 | skeletal muscle contraction (GO:0003009) | 4.50213957 |
| 35 | eye photoreceptor cell differentiation (GO:0001754) | 4.48071370 |
| 36 | photoreceptor cell differentiation (GO:0046530) | 4.48071370 |
| 37 | creatine metabolic process (GO:0006600) | 4.46399901 |
| 38 | thymic T cell selection (GO:0045061) | 4.44305831 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 4.42609260 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.42040451 |
| 41 | negative regulation of protein localization to cell surface (GO:2000009) | 4.39792489 |
| 42 | T cell selection (GO:0045058) | 4.37320970 |
| 43 | isoprenoid biosynthetic process (GO:0008299) | 4.33275872 |
| 44 | amino acid import (GO:0043090) | 4.32731633 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 4.27363494 |
| 46 | myelin maintenance (GO:0043217) | 4.19511397 |
| 47 | asymmetric protein localization (GO:0008105) | 4.19372480 |
| 48 | T cell migration (GO:0072678) | 4.14877781 |
| 49 | presynaptic membrane assembly (GO:0097105) | 4.14235945 |
| 50 | actin-mediated cell contraction (GO:0070252) | 4.14047628 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 4.11968761 |
| 52 | presynaptic membrane organization (GO:0097090) | 4.11595951 |
| 53 | cytidine metabolic process (GO:0046087) | 4.09260760 |
| 54 | cytidine catabolic process (GO:0006216) | 4.09260760 |
| 55 | cytidine deamination (GO:0009972) | 4.09260760 |
| 56 | regulation of relaxation of muscle (GO:1901077) | 4.08744990 |
| 57 | substantia nigra development (GO:0021762) | 4.08677988 |
| 58 | virion attachment to host cell (GO:0019062) | 4.07337442 |
| 59 | adhesion of symbiont to host cell (GO:0044650) | 4.07337442 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 4.05363066 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.01673864 |
| 62 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.98815359 |
| 63 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.94179286 |
| 64 | Peyers patch development (GO:0048541) | 3.91432052 |
| 65 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.91432052 |
| 66 | neuron cell-cell adhesion (GO:0007158) | 3.88818718 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.87634477 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.85351363 |
| 69 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.82480470 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.80653859 |
| 71 | peripheral nervous system axon ensheathment (GO:0032292) | 3.79477730 |
| 72 | myelination in peripheral nervous system (GO:0022011) | 3.79477730 |
| 73 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.77715518 |
| 74 | astrocyte development (GO:0014002) | 3.77006139 |
| 75 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.70704739 |
| 76 | response to methylmercury (GO:0051597) | 3.70669732 |
| 77 | histone H2B ubiquitination (GO:0033523) | 3.67954662 |
| 78 | apical protein localization (GO:0045176) | 3.67173188 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61928270 |
| 80 | establishment of mitochondrion localization (GO:0051654) | 3.59123700 |
| 81 | tolerance induction (GO:0002507) | 3.58756999 |
| 82 | transmission of nerve impulse (GO:0019226) | 3.58546051 |
| 83 | positive regulation of action potential (GO:0045760) | 3.56395142 |
| 84 | protein palmitoylation (GO:0018345) | 3.54602939 |
| 85 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.49103970 |
| 86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.45503142 |
| 87 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.45503142 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 3.45495806 |
| 89 | amyloid precursor protein metabolic process (GO:0042982) | 3.44570048 |
| 90 | interferon-gamma production (GO:0032609) | 3.43712477 |
| 91 | positive regulation of tolerance induction (GO:0002645) | 3.43213496 |
| 92 | glycosylceramide metabolic process (GO:0006677) | 3.42788921 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.42641547 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.41906851 |
| 95 | membrane tubulation (GO:0097320) | 3.37846281 |
| 96 | GPI anchor biosynthetic process (GO:0006506) | 3.34722565 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 3.34082337 |
| 98 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.32730415 |
| 99 | response to lipoprotein particle (GO:0055094) | 3.30610337 |
| 100 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.29960147 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.26709421 |
| 102 | import into cell (GO:0098657) | 3.24680830 |
| 103 | * T cell receptor signaling pathway (GO:0050852) | 3.23901263 |
| 104 | cellular response to epinephrine stimulus (GO:0071872) | 3.23747117 |
| 105 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.22016929 |
| 106 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.21403588 |
| 107 | megakaryocyte development (GO:0035855) | 3.20683647 |
| 108 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.20157072 |
| 109 | GPI anchor metabolic process (GO:0006505) | 3.19759998 |
| 110 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.16906465 |
| 111 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.16571986 |
| 112 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.16475966 |
| 113 | negative regulation of axonogenesis (GO:0050771) | 3.16471871 |
| 114 | regulation of granulocyte differentiation (GO:0030852) | 3.14870599 |
| 115 | * negative regulation of T cell apoptotic process (GO:0070233) | 3.11634927 |
| 116 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11524977 |
| 117 | mast cell activation (GO:0045576) | 3.09115402 |
| 118 | regulation of tolerance induction (GO:0002643) | 3.08105356 |
| 119 | negative regulation of axon extension (GO:0030517) | 3.07699780 |
| 120 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.07090815 |
| 121 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05834899 |
| 122 | actin filament-based movement (GO:0030048) | 3.05382317 |
| 123 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.02644974 |
| 124 | T cell homeostasis (GO:0043029) | 3.01940956 |
| 125 | microtubule polymerization or depolymerization (GO:0031109) | 2.98396331 |
| 126 | regulation of necroptotic process (GO:0060544) | 2.98307392 |
| 127 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.97744506 |
| 128 | magnesium ion transport (GO:0015693) | 2.95546314 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95513037 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.94937998 |
| 131 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.94937998 |
| 132 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.94564026 |
| 133 | skeletal muscle adaptation (GO:0043501) | 2.94522524 |
| 134 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.94434103 |
| 135 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.93536968 |
| 136 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.93406510 |
| 137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.92779459 |
| 138 | peripheral nervous system development (GO:0007422) | 2.92110847 |
| 139 | negative regulation of JUN kinase activity (GO:0043508) | 2.91456421 |
| 140 | axon development (GO:0061564) | 2.90802544 |
| 141 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.90672404 |
| 142 | negative regulation of interleukin-10 production (GO:0032693) | 2.90179649 |
| 143 | negative regulation of myoblast differentiation (GO:0045662) | 2.89182467 |
| 144 | limb bud formation (GO:0060174) | 2.87192732 |
| 145 | ear development (GO:0043583) | 2.87070071 |
| 146 | negative regulation of necroptotic process (GO:0060546) | 2.86707535 |
| 147 | positive regulation of glial cell differentiation (GO:0045687) | 2.86290174 |
| 148 | positive regulation of neurological system process (GO:0031646) | 2.85754370 |
| 149 | response to epinephrine (GO:0071871) | 2.83712801 |
| 150 | adhesion of symbiont to host (GO:0044406) | 2.83633081 |
| 151 | Leydig cell differentiation (GO:0033327) | 2.82482851 |
| 152 | regulation of cell killing (GO:0031341) | 2.82138726 |
| 153 | response to hepatocyte growth factor (GO:0035728) | 2.81687478 |
| 154 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.81687478 |
| 155 | skeletal muscle tissue regeneration (GO:0043403) | 2.81198210 |
| 156 | alpha-beta T cell differentiation (GO:0046632) | 2.80058387 |
| 157 | positive regulation of cell killing (GO:0031343) | 2.79569335 |
| 158 | striated muscle contraction (GO:0006941) | 2.79150649 |
| 159 | glial cell development (GO:0021782) | 2.78924345 |
| 160 | mannosylation (GO:0097502) | 2.78632527 |
| 161 | positive regulation of actin filament depolymerization (GO:0030836) | 2.77954649 |
| 162 | enteric nervous system development (GO:0048484) | 2.77671546 |
| 163 | negative regulation of adaptive immune response (GO:0002820) | 2.77150936 |
| 164 | negative regulation of stress fiber assembly (GO:0051497) | 2.76835808 |
| 165 | natural killer cell differentiation (GO:0001779) | 2.76701481 |
| 166 | T cell differentiation (GO:0030217) | 2.75766489 |
| 167 | nucleotide transmembrane transport (GO:1901679) | 2.75520117 |
| 168 | regulation of somitogenesis (GO:0014807) | 2.73710510 |
| 169 | alpha-beta T cell activation (GO:0046631) | 2.73182880 |
| 170 | adult walking behavior (GO:0007628) | 2.71288190 |
| 171 | positive regulation of gliogenesis (GO:0014015) | 2.71274817 |
| 172 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.70300089 |
| 173 | myofibril assembly (GO:0030239) | 2.69080555 |
| 174 | purine nucleotide salvage (GO:0032261) | 2.68658466 |
| 175 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.68646922 |
| 176 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.68583043 |
| 177 | neural nucleus development (GO:0048857) | 2.67253013 |
| 178 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.66923070 |
| 179 | glial cell differentiation (GO:0010001) | 2.66661827 |
| 180 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.66226083 |
| 181 | neuron remodeling (GO:0016322) | 2.64248239 |
| 182 | lymphocyte homeostasis (GO:0002260) | 2.64082310 |
| 183 | organ growth (GO:0035265) | 2.63727549 |
| 184 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62632814 |
| 185 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.62238892 |
| 186 | amyloid precursor protein catabolic process (GO:0042987) | 2.61200609 |
| 187 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.60020929 |
| 188 | negative regulation of acute inflammatory response (GO:0002674) | 2.59538835 |
| 189 | leukocyte degranulation (GO:0043299) | 2.59433861 |
| 190 | leukocyte aggregation (GO:0070486) | 2.58560619 |
| 191 | ceramide biosynthetic process (GO:0046513) | 2.57237120 |
| 192 | peptidyl-cysteine modification (GO:0018198) | 2.57120909 |
| 193 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.55364027 |
| 194 | protein neddylation (GO:0045116) | 2.55001574 |
| 195 | central nervous system myelination (GO:0022010) | 11.1144830 |
| 196 | axon ensheathment in central nervous system (GO:0032291) | 11.1144830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.53455426 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.84782955 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.29815096 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.66840082 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51759758 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.48872914 |
| 7 | * MYB_26560356_Chip-Seq_TH2_Human | 3.38749158 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38460467 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.99080580 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97178542 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.89956451 |
| 12 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.84135498 |
| 13 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.73127426 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62331764 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.62018601 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.58024771 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.54416594 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46583707 |
| 19 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.45536559 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44824359 |
| 21 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.35435304 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.31890549 |
| 23 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.25616175 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25307770 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20028318 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19226666 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.16955806 |
| 28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.16217309 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.09435802 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.08654884 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05661306 |
| 32 | * MAF_26560356_Chip-Seq_TH2_Human | 2.04941330 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04930718 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.02303697 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 2.00982778 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93674329 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82252234 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81479099 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80078054 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80015067 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79705866 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76809718 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74133232 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71316997 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70639052 |
| 46 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.70583673 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.69003048 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67450191 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67332371 |
| 50 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64928158 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64880757 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64031512 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63517327 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63105408 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61435700 |
| 56 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60646169 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59865792 |
| 58 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.59617652 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58303080 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55748492 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54486062 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50856934 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50526565 |
| 64 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50253239 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49229659 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48666217 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47387765 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47345478 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45207572 |
| 70 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44486201 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43987428 |
| 72 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43883374 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43556120 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41395020 |
| 75 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40234221 |
| 76 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.39924052 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39797757 |
| 78 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39560170 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39382657 |
| 80 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.37692649 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36766771 |
| 82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36434962 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35992221 |
| 84 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.35907733 |
| 85 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.35228351 |
| 86 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34854956 |
| 87 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.34838225 |
| 88 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33915184 |
| 89 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33915184 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33819427 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32504820 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32429084 |
| 93 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31387040 |
| 94 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30874135 |
| 95 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30415211 |
| 96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29855253 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29409461 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28972412 |
| 99 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.28374348 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28129370 |
| 101 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27951856 |
| 102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.27843986 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27744637 |
| 104 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26352340 |
| 105 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26286911 |
| 106 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25765937 |
| 107 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25163808 |
| 108 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23728506 |
| 109 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23516140 |
| 110 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23031019 |
| 111 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22743450 |
| 112 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20345421 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20155895 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20010154 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19668152 |
| 116 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18292800 |
| 117 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.18209384 |
| 118 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17909822 |
| 119 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17748726 |
| 120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17180177 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16782809 |
| 122 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16512818 |
| 123 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16486790 |
| 124 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15750772 |
| 125 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15525478 |
| 126 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.15273615 |
| 127 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14146512 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14115396 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13991341 |
| 130 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13638630 |
| 131 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13219580 |
| 132 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13045886 |
| 133 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11316657 |
| 134 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.11106464 |
| 135 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10206305 |
| 136 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10047450 |
| 137 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.09488195 |
| 138 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.09485758 |
| 139 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09294952 |
| 140 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08775851 |
| 141 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08729698 |
| 142 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08231098 |
| 143 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07419552 |
| 144 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.06173934 |
| 145 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05766360 |
| 146 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.04636190 |
| 147 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04604621 |
| 148 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03615127 |
| 149 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03615127 |
| 150 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03544844 |
| 151 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02832818 |
| 152 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02646140 |
| 153 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.02621569 |
| 154 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02133115 |
| 155 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01659472 |
| 156 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.01408698 |
| 157 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01122875 |
| 158 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00629581 |
| 159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00182600 |
| 160 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99740442 |
| 161 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99023233 |
| 162 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98467628 |
| 163 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98434360 |
| 164 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97872099 |
| 165 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97504904 |
| 166 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94053140 |
| 167 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.93878198 |
| 168 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89896555 |
| 169 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89226722 |
| 170 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87029348 |
| 171 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86761101 |
| 172 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84827929 |
| 173 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83123666 |
| 174 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82694326 |
| 175 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82557708 |
| 176 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82137556 |
| 177 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81016988 |
| 178 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.80993035 |
| 179 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78780400 |
| 180 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.77240393 |
| 181 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77010152 |
| 182 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76624165 |
| 183 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75240759 |
| 184 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75018061 |
| 185 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74941987 |
| 186 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73321239 |
| 187 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.73200998 |
| 188 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73131235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 6.09687342 |
| 2 | MP0003646_muscle_fatigue | 4.89128191 |
| 3 | MP0003136_yellow_coat_color | 3.58270345 |
| 4 | MP0003880_abnormal_central_pattern | 3.48374245 |
| 5 | MP0003690_abnormal_glial_cell | 3.17357013 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.11263115 |
| 7 | MP0001529_abnormal_vocalization | 3.03948595 |
| 8 | MP0004742_abnormal_vestibular_system | 2.94007585 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.86232874 |
| 10 | MP0005171_absent_coat_pigmentation | 2.84519506 |
| 11 | MP0000749_muscle_degeneration | 2.76187238 |
| 12 | MP0004381_abnormal_hair_follicle | 2.67450879 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.64266986 |
| 14 | MP0004885_abnormal_endolymph | 2.61615505 |
| 15 | MP0001905_abnormal_dopamine_level | 2.61047527 |
| 16 | * MP0005464_abnormal_platelet_physiology | 2.54182300 |
| 17 | MP0004270_analgesia | 2.52465651 |
| 18 | MP0001800_abnormal_humoral_immune | 2.44346992 |
| 19 | MP0005410_abnormal_fertilization | 2.43049031 |
| 20 | MP0003436_decreased_susceptibility_to | 2.35098928 |
| 21 | MP0003724_increased_susceptibility_to | 2.33852360 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.32972527 |
| 23 | MP0003634_abnormal_glial_cell | 2.32290532 |
| 24 | MP0005451_abnormal_body_composition | 2.30709377 |
| 25 | MP0002272_abnormal_nervous_system | 2.29852591 |
| 26 | MP0004142_abnormal_muscle_tone | 2.28520241 |
| 27 | MP0005409_darkened_coat_color | 2.26480411 |
| 28 | MP0001485_abnormal_pinna_reflex | 2.25239183 |
| 29 | * MP0002398_abnormal_bone_marrow | 2.25090890 |
| 30 | MP0000703_abnormal_thymus_morphology | 2.22559157 |
| 31 | MP0000751_myopathy | 2.20467512 |
| 32 | * MP0002420_abnormal_adaptive_immunity | 2.18421384 |
| 33 | MP0001486_abnormal_startle_reflex | 2.16544312 |
| 34 | MP0000778_abnormal_nervous_system | 2.14875716 |
| 35 | * MP0001819_abnormal_immune_cell | 2.13920188 |
| 36 | MP0002106_abnormal_muscle_physiology | 2.12720020 |
| 37 | * MP0002723_abnormal_immune_serum | 2.12236143 |
| 38 | * MP0004130_abnormal_muscle_cell | 1.96977626 |
| 39 | MP0000383_abnormal_hair_follicle | 1.96515334 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.94824966 |
| 41 | * MP0009333_abnormal_splenocyte_physiolog | 1.91934066 |
| 42 | * MP0000716_abnormal_immune_system | 1.87690477 |
| 43 | * MP0000689_abnormal_spleen_morphology | 1.87506698 |
| 44 | MP0003329_amyloid_beta_deposits | 1.87470827 |
| 45 | * MP0002722_abnormal_immune_system | 1.85841911 |
| 46 | * MP0005025_abnormal_response_to | 1.84881861 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.83445335 |
| 48 | MP0000462_abnormal_digestive_system | 1.78573500 |
| 49 | MP0002064_seizures | 1.77947906 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.76635690 |
| 51 | MP0009785_altered_susceptibility_to | 1.75857200 |
| 52 | MP0006082_CNS_inflammation | 1.73713632 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.73056134 |
| 54 | MP0004087_abnormal_muscle_fiber | 1.72170752 |
| 55 | MP0002229_neurodegeneration | 1.68407965 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.68126503 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.64996009 |
| 58 | MP0001873_stomach_inflammation | 1.64505656 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 1.64466452 |
| 60 | MP0003632_abnormal_nervous_system | 1.64115318 |
| 61 | MP0005369_muscle_phenotype | 1.62983899 |
| 62 | MP0002419_abnormal_innate_immunity | 1.61973536 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.61790564 |
| 64 | MP0000566_synostosis | 1.61667427 |
| 65 | MP0003866_abnormal_defecation | 1.59992293 |
| 66 | MP0001851_eye_inflammation | 1.58692444 |
| 67 | MP0000685_abnormal_immune_system | 1.58069874 |
| 68 | * MP0002429_abnormal_blood_cell | 1.57653924 |
| 69 | MP0002405_respiratory_system_inflammati | 1.55866477 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.54725729 |
| 71 | MP0003938_abnormal_ear_development | 1.53859638 |
| 72 | MP0003303_peritoneal_inflammation | 1.52636903 |
| 73 | MP0004084_abnormal_cardiac_muscle | 1.51370884 |
| 74 | MP0008057_abnormal_DNA_replication | 1.50604559 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.45962325 |
| 76 | MP0010155_abnormal_intestine_physiology | 1.44613098 |
| 77 | MP0002166_altered_tumor_susceptibility | 1.43481094 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.43026713 |
| 79 | MP0002269_muscular_atrophy | 1.42628740 |
| 80 | MP0003763_abnormal_thymus_physiology | 1.36963549 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 1.36556870 |
| 82 | MP0005620_abnormal_muscle_contractility | 1.35813615 |
| 83 | MP0005330_cardiomyopathy | 1.33803912 |
| 84 | MP0005408_hypopigmentation | 1.31095014 |
| 85 | MP0001963_abnormal_hearing_physiology | 1.30242938 |
| 86 | MP0001299_abnormal_eye_distance/ | 1.29322392 |
| 87 | MP0000955_abnormal_spinal_cord | 1.26863042 |
| 88 | * MP0002752_abnormal_somatic_nervous | 1.25210875 |
| 89 | MP0009046_muscle_twitch | 1.24223215 |
| 90 | * MP0002882_abnormal_neuron_morphology | 1.24079501 |
| 91 | MP0009745_abnormal_behavioral_response | 1.22778830 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.17339238 |
| 93 | MP0004484_altered_response_of | 1.16515086 |
| 94 | MP0001440_abnormal_grooming_behavior | 1.15558355 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 1.15270362 |
| 96 | MP0008569_lethality_at_weaning | 1.15252549 |
| 97 | MP0002132_abnormal_respiratory_system | 1.14897899 |
| 98 | MP0001845_abnormal_inflammatory_respons | 1.14281744 |
| 99 | MP0002006_tumorigenesis | 1.12784907 |
| 100 | MP0004147_increased_porphyrin_level | 1.12297103 |
| 101 | MP0002009_preneoplasia | 1.11309142 |
| 102 | MP0004947_skin_inflammation | 1.10934356 |
| 103 | MP0003937_abnormal_limbs/digits/tail_de | 1.10584220 |
| 104 | MP0005266_abnormal_metabolism | 1.08124394 |
| 105 | MP0002066_abnormal_motor_capabilities/c | 1.08038843 |
| 106 | MP0005195_abnormal_posterior_eye | 1.07779593 |
| 107 | MP0002067_abnormal_sensory_capabilities | 1.06366652 |
| 108 | MP0000647_abnormal_sebaceous_gland | 1.04616424 |
| 109 | MP0000750_abnormal_muscle_regeneration | 1.04549921 |
| 110 | MP0004233_abnormal_muscle_weight | 1.04458170 |
| 111 | MP0005671_abnormal_response_to | 1.02152175 |
| 112 | MP0000747_muscle_weakness | 0.98739528 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97968409 |
| 114 | MP0001970_abnormal_pain_threshold | 0.97659391 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.96859609 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 0.96859609 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 0.95177316 |
| 118 | MP0003828_pulmonary_edema | 0.94481935 |
| 119 | MP0004924_abnormal_behavior | 0.92574258 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.92574258 |
| 121 | MP0003631_nervous_system_phenotype | 0.92223247 |
| 122 | * MP0003635_abnormal_synaptic_transmissio | 0.92133157 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.92025594 |
| 124 | MP0005385_cardiovascular_system_phenoty | 0.91047066 |
| 125 | MP0001544_abnormal_cardiovascular_syste | 0.91047066 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.90815655 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.90741657 |
| 128 | MP0008469_abnormal_protein_level | 0.89430957 |
| 129 | MP0008260_abnormal_autophagy | 0.88952885 |
| 130 | MP0004510_myositis | 0.88208416 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.88134884 |
| 132 | MP0005623_abnormal_meninges_morphology | 0.88118441 |
| 133 | MP0000467_abnormal_esophagus_morphology | 0.86932342 |
| 134 | MP0002938_white_spotting | 0.86897871 |
| 135 | MP0000604_amyloidosis | 0.86653174 |
| 136 | MP0002736_abnormal_nociception_after | 0.86402203 |
| 137 | * MP0002019_abnormal_tumor_incidence | 0.86350148 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.86263583 |
| 139 | MP0005253_abnormal_eye_physiology | 0.85438506 |
| 140 | MP0002933_joint_inflammation | 0.85412478 |
| 141 | MP0000372_irregular_coat_pigmentation | 0.85402804 |
| 142 | MP0006035_abnormal_mitochondrial_morpho | 0.84569829 |
| 143 | MP0000026_abnormal_inner_ear | 0.83147448 |
| 144 | MP0002277_abnormal_respiratory_mucosa | 0.80285660 |
| 145 | MP0001968_abnormal_touch/_nociception | 0.80151803 |
| 146 | MP0001346_abnormal_lacrimal_gland | 0.79969008 |
| 147 | MP0004043_abnormal_pH_regulation | 0.79532922 |
| 148 | MP0005310_abnormal_salivary_gland | 0.79060818 |
| 149 | MP0000762_abnormal_tongue_morphology | 0.78955121 |
| 150 | MP0009250_abnormal_appendicular_skeleto | 0.78042580 |
| 151 | MP0004859_abnormal_synaptic_plasticity | 0.75553889 |
| 152 | MP0005083_abnormal_biliary_tract | 0.75493725 |
| 153 | MP0009278_abnormal_bone_marrow | 0.75135108 |
| 154 | MP0001727_abnormal_embryo_implantation | 0.74895891 |
| 155 | MP0003698_abnormal_male_reproductive | 0.74068913 |
| 156 | MP0002837_dystrophic_cardiac_calcinosis | 0.72218105 |
| 157 | MP0006072_abnormal_retinal_apoptosis | 0.70771645 |
| 158 | MP0002184_abnormal_innervation | 0.68778256 |
| 159 | MP0002152_abnormal_brain_morphology | 0.68614788 |
| 160 | MP0005387_immune_system_phenotype | 0.68329144 |
| 161 | MP0001790_abnormal_immune_system | 0.68329144 |
| 162 | MP0002733_abnormal_thermal_nociception | 0.67987197 |
| 163 | MP0000733_abnormal_muscle_development | 0.67680381 |
| 164 | MP0001340_abnormal_eyelid_morphology | 0.67373946 |
| 165 | MP0002735_abnormal_chemical_nociception | 0.66650837 |
| 166 | MP0001348_abnormal_lacrimal_gland | 0.66432705 |
| 167 | MP0001986_abnormal_taste_sensitivity | 0.65604606 |
| 168 | MP0002102_abnormal_ear_morphology | 0.65342221 |
| 169 | MP0005535_abnormal_body_temperature | 0.63255314 |
| 170 | MP0009763_increased_sensitivity_to | 0.63209328 |
| 171 | MP0003045_fibrosis | 0.61546156 |
| 172 | MP0005075_abnormal_melanosome_morpholog | 0.61258130 |
| 173 | * MP0005000_abnormal_immune_tolerance | 0.60811335 |
| 174 | * MP0004134_abnormal_chest_morphology | 0.60409244 |
| 175 | MP0009765_abnormal_xenobiotic_induced | 0.59657686 |
| 176 | MP0001853_heart_inflammation | 0.59569341 |
| 177 | MP0002063_abnormal_learning/memory/cond | 0.59215526 |
| 178 | MP0002133_abnormal_respiratory_system | 0.58355429 |
| 179 | MP0005388_respiratory_system_phenotype | 0.58355429 |
| 180 | MP0001663_abnormal_digestive_system | 0.57566049 |
| 181 | MP0009764_decreased_sensitivity_to | 0.57036999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.59907160 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.21164208 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.79961495 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.79961495 |
| 5 | Exercise-induced myalgia (HP:0003738) | 6.44586000 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 5.77789391 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.37885497 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 5.29654462 |
| 9 | Parakeratosis (HP:0001036) | 5.17553789 |
| 10 | Abnormality of the corticospinal tract (HP:0002492) | 5.07830321 |
| 11 | Neurofibrillary tangles (HP:0002185) | 5.06851615 |
| 12 | Peripheral hypomyelination (HP:0007182) | 4.85504500 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.35244210 |
| 14 | Distal arthrogryposis (HP:0005684) | 4.27293857 |
| 15 | Myopathic facies (HP:0002058) | 4.20205421 |
| 16 | Rhabdomyolysis (HP:0003201) | 4.16826123 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.82043790 |
| 18 | Subaortic stenosis (HP:0001682) | 3.81286191 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.81286191 |
| 20 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.80507479 |
| 21 | Hypoplastic pelvis (HP:0008839) | 3.78772807 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.78146981 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 3.72871910 |
| 24 | Myoglobinuria (HP:0002913) | 3.63315774 |
| 25 | Abnormal auditory evoked potentials (HP:0006958) | 3.62229092 |
| 26 | Cerebral hypomyelination (HP:0006808) | 3.50775146 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.45536723 |
| 28 | Neck muscle weakness (HP:0000467) | 3.39252118 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.38642806 |
| 30 | Spastic gait (HP:0002064) | 3.35859018 |
| 31 | Premature skin wrinkling (HP:0100678) | 3.35282594 |
| 32 | Autoimmune hemolytic anemia (HP:0001890) | 3.35101275 |
| 33 | Onion bulb formation (HP:0003383) | 3.30875772 |
| 34 | Rimmed vacuoles (HP:0003805) | 3.29078356 |
| 35 | Muscle stiffness (HP:0003552) | 3.26007309 |
| 36 | Abnormality of T cells (HP:0002843) | 3.24487912 |
| 37 | Prolonged bleeding time (HP:0003010) | 3.19905115 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 3.19637648 |
| 39 | Akinesia (HP:0002304) | 3.19176423 |
| 40 | Abnormality of glycolysis (HP:0004366) | 3.18190733 |
| 41 | Increased serum pyruvate (HP:0003542) | 3.18190733 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.12919465 |
| 43 | Ulnar deviation of the wrist (HP:0003049) | 3.12834145 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 3.09598170 |
| 45 | Round ear (HP:0100830) | 3.06300766 |
| 46 | Myositis (HP:0100614) | 3.05678824 |
| 47 | Difficulty running (HP:0009046) | 3.02553063 |
| 48 | Retinal dysplasia (HP:0007973) | 2.99027254 |
| 49 | Small epiphyses (HP:0010585) | 2.92708049 |
| 50 | Alacrima (HP:0000522) | 2.90017040 |
| 51 | Absent septum pellucidum (HP:0001331) | 2.88275787 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.84366683 |
| 53 | Adrenal hypoplasia (HP:0000835) | 2.82548412 |
| 54 | Supranuclear gaze palsy (HP:0000605) | 2.79719999 |
| 55 | Anteriorly placed anus (HP:0001545) | 2.76855986 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 2.76776997 |
| 57 | Areflexia of lower limbs (HP:0002522) | 2.76333438 |
| 58 | Partial agenesis of the corpus callosum (HP:0001338) | 2.73228100 |
| 59 | Encephalitis (HP:0002383) | 2.72497807 |
| 60 | White forelock (HP:0002211) | 2.71512444 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.70212562 |
| 62 | Dysmetria (HP:0001310) | 2.69347150 |
| 63 | Intention tremor (HP:0002080) | 2.68468254 |
| 64 | Decreased lacrimation (HP:0000633) | 2.65580174 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.64437069 |
| 66 | Anomalous pulmonary venous return (HP:0010772) | 2.63347888 |
| 67 | Abnormality of the septum pellucidum (HP:0007375) | 2.62665214 |
| 68 | Patchy hypopigmentation of hair (HP:0011365) | 2.62613139 |
| 69 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.60424623 |
| 70 | Chin dimple (HP:0010751) | 2.59157116 |
| 71 | Hypomagnesemia (HP:0002917) | 2.59118733 |
| 72 | Chest pain (HP:0100749) | 2.55922182 |
| 73 | Spastic paraparesis (HP:0002313) | 2.53912938 |
| 74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.53089047 |
| 75 | Optic neuritis (HP:0100653) | 2.52348584 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.52348584 |
| 77 | Granulocytopenia (HP:0001913) | 2.51653648 |
| 78 | Morphological abnormality of the inner ear (HP:0011390) | 2.47226987 |
| 79 | Cupped ear (HP:0000378) | 2.46821647 |
| 80 | Frequent falls (HP:0002359) | 2.45690573 |
| 81 | Barrel-shaped chest (HP:0001552) | 2.44351948 |
| 82 | Eosinophilia (HP:0001880) | 2.43587192 |
| 83 | Malignant hyperthermia (HP:0002047) | 2.43291622 |
| 84 | Renal Fanconi syndrome (HP:0001994) | 2.42319961 |
| 85 | Stridor (HP:0010307) | 2.40993934 |
| 86 | Absent phalangeal crease (HP:0006109) | 2.40011298 |
| 87 | Leukodystrophy (HP:0002415) | 2.38340989 |
| 88 | Abnormality of the calf musculature (HP:0001430) | 2.38319204 |
| 89 | T lymphocytopenia (HP:0005403) | 2.37752621 |
| 90 | Orchitis (HP:0100796) | 2.37264105 |
| 91 | Generalized muscle weakness (HP:0003324) | 2.37109476 |
| 92 | Recurrent viral infections (HP:0004429) | 2.36394141 |
| 93 | EMG: neuropathic changes (HP:0003445) | 2.35881565 |
| 94 | Epistaxis (HP:0000421) | 2.32852116 |
| 95 | Calcaneovalgus deformity (HP:0001848) | 2.32625057 |
| 96 | Scanning speech (HP:0002168) | 2.32541265 |
| 97 | Termporal pattern (HP:0011008) | 2.32262549 |
| 98 | Insidious onset (HP:0003587) | 2.32262549 |
| 99 | Leukocytosis (HP:0001974) | 2.32031950 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 2.30409940 |
| 101 | Meningitis (HP:0001287) | 2.30176352 |
| 102 | Humeroradial synostosis (HP:0003041) | 2.28622501 |
| 103 | Synostosis involving the elbow (HP:0003938) | 2.28622501 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.28318033 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 2.27380866 |
| 106 | IgG deficiency (HP:0004315) | 2.27168896 |
| 107 | Cerebral hemorrhage (HP:0001342) | 2.26661558 |
| 108 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.25754736 |
| 109 | IgM deficiency (HP:0002850) | 2.24866674 |
| 110 | Hypoplasia of the iris (HP:0007676) | 2.24146199 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 2.23251433 |
| 112 | Autoamputation (HP:0001218) | 2.22326440 |
| 113 | Abnormality of the pulmonary veins (HP:0011718) | 2.22104601 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 2.21394516 |
| 115 | Stomatitis (HP:0010280) | 2.21203507 |
| 116 | Hepatosplenomegaly (HP:0001433) | 2.20805653 |
| 117 | Spontaneous hematomas (HP:0007420) | 2.20218770 |
| 118 | Split foot (HP:0001839) | 2.18923792 |
| 119 | Abnormality of T cell number (HP:0011839) | 2.18487844 |
| 120 | Recurrent abscess formation (HP:0002722) | 2.18193241 |
| 121 | Thickened helices (HP:0000391) | 2.17963551 |
| 122 | Pustule (HP:0200039) | 2.16433585 |
| 123 | Atonic seizures (HP:0010819) | 2.15203056 |
| 124 | Combined immunodeficiency (HP:0005387) | 2.13951224 |
| 125 | Myotonia (HP:0002486) | 2.13561086 |
| 126 | 3-Methylglutaconic aciduria (HP:0003535) | 2.12159121 |
| 127 | Sudden death (HP:0001699) | 2.11412546 |
| 128 | Increased IgM level (HP:0003496) | 2.11408061 |
| 129 | Increased circulating renin level (HP:0000848) | 2.10364560 |
| 130 | Petechiae (HP:0000967) | 2.08947253 |
| 131 | Progressive muscle weakness (HP:0003323) | 2.07462648 |
| 132 | Increased muscle lipid content (HP:0009058) | 2.05542912 |
| 133 | Abnormal finger flexion creases (HP:0006143) | 2.05458613 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05430904 |
| 135 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05430904 |
| 136 | CNS hypomyelination (HP:0003429) | 2.03691163 |
| 137 | Inflammation of the large intestine (HP:0002037) | 2.02777235 |
| 138 | Weak cry (HP:0001612) | 2.02429275 |
| 139 | Obstructive lung disease (HP:0006536) | 2.01607339 |
| 140 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01607339 |
| 141 | Deformed tarsal bones (HP:0008119) | 2.01586695 |
| 142 | Hyperkalemia (HP:0002153) | 2.01405756 |
| 143 | Bulbar palsy (HP:0001283) | 1.99925681 |
| 144 | Increased connective tissue (HP:0009025) | 1.98687574 |
| 145 | Gastrointestinal inflammation (HP:0004386) | 1.98272015 |
| 146 | Facial diplegia (HP:0001349) | 1.97648523 |
| 147 | Gastrointestinal stroma tumor (HP:0100723) | 1.96203823 |
| 148 | Distal lower limb muscle weakness (HP:0009053) | 1.95169899 |
| 149 | Fatigue (HP:0012378) | 1.94498608 |
| 150 | Septo-optic dysplasia (HP:0100842) | 1.93549599 |
| 151 | Keratoconjunctivitis sicca (HP:0001097) | 1.92385919 |
| 152 | Muscle fiber splitting (HP:0003555) | 1.92362622 |
| 153 | Nemaline bodies (HP:0003798) | 1.91333093 |
| 154 | Gingival bleeding (HP:0000225) | 1.90617317 |
| 155 | Abnormal large intestine physiology (HP:0012700) | 1.87097750 |
| 156 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84729627 |
| 157 | Absent/shortened dynein arms (HP:0200106) | 1.84729627 |
| 158 | Esophageal atresia (HP:0002032) | 1.83847435 |
| 159 | Abnormality of B cell number (HP:0010975) | 1.82995474 |
| 160 | Paralysis (HP:0003470) | 1.82739674 |
| 161 | Type II lissencephaly (HP:0007260) | 1.81967505 |
| 162 | Bowel incontinence (HP:0002607) | 1.81870531 |
| 163 | Keratoconjunctivitis (HP:0001096) | 1.80746174 |
| 164 | Vasculitis (HP:0002633) | 1.79951586 |
| 165 | Abnormality of macrophages (HP:0004311) | 1.79205669 |
| 166 | Abolished electroretinogram (ERG) (HP:0000550) | 1.79109053 |
| 167 | Hyporeflexia of lower limbs (HP:0002600) | 1.78379531 |
| 168 | Arterial thrombosis (HP:0004420) | 1.77981447 |
| 169 | Epiphyseal dysplasia (HP:0002656) | 1.77786867 |
| 170 | Abnormal platelet volume (HP:0011876) | 1.77636473 |
| 171 | Metabolic alkalosis (HP:0200114) | 1.76841358 |
| 172 | Meningocele (HP:0002435) | 1.76740925 |
| 173 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.76315345 |
| 174 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75747563 |
| 175 | Asplenia (HP:0001746) | 1.75563444 |
| 176 | Erythroderma (HP:0001019) | 1.74482623 |
| 177 | Generalized myoclonic seizures (HP:0002123) | 1.74080220 |
| 178 | Gowers sign (HP:0003391) | 1.73576806 |
| 179 | Duplicated collecting system (HP:0000081) | 1.73473351 |
| 180 | Seborrheic dermatitis (HP:0001051) | 1.72803030 |
| 181 | Relative macrocephaly (HP:0004482) | 1.72233804 |
| 182 | Increased hepatocellular lipid droplets (HP:0006565) | 1.71686420 |
| 183 | Conical tooth (HP:0000698) | 1.70089554 |
| 184 | Hypokalemic alkalosis (HP:0001949) | 1.67966700 |
| 185 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.67766236 |
| 186 | Myelomeningocele (HP:0002475) | 1.66806337 |
| 187 | Steppage gait (HP:0003376) | 1.66752768 |
| 188 | Widely spaced teeth (HP:0000687) | 1.65306729 |
| 189 | Stomach cancer (HP:0012126) | 1.64861598 |
| 190 | Lower limb muscle weakness (HP:0007340) | 1.63787268 |
| 191 | Abnormality of eosinophils (HP:0001879) | 1.62222429 |
| 192 | Clumsiness (HP:0002312) | 1.59774893 |
| 193 | Irregular epiphyses (HP:0010582) | 1.59506331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.18634290 |
| 2 | OXSR1 | 4.13159142 |
| 3 | EPHB1 | 3.95160304 |
| 4 | TNIK | 3.59024167 |
| 5 | TTN | 3.12502667 |
| 6 | PIK3CG | 2.81586665 |
| 7 | TYRO3 | 2.65003772 |
| 8 | MAP2K3 | 2.62499848 |
| 9 | PKN1 | 2.55520028 |
| 10 | TAOK3 | 2.50291347 |
| 11 | BCR | 2.33082316 |
| 12 | PBK | 2.25339611 |
| 13 | WNK4 | 2.24986261 |
| 14 | ZAP70 | 2.21026517 |
| 15 | RIPK4 | 2.19142858 |
| 16 | NEK6 | 2.17292850 |
| 17 | BTK | 2.09647395 |
| 18 | ICK | 1.94850622 |
| 19 | TEC | 1.94730416 |
| 20 | CDK19 | 1.94534611 |
| 21 | SYK | 1.89395909 |
| 22 | MST4 | 1.86622920 |
| 23 | KDR | 1.79259820 |
| 24 | CSNK1G3 | 1.78224960 |
| 25 | MET | 1.74810244 |
| 26 | GRK6 | 1.70407399 |
| 27 | WNK1 | 1.70210458 |
| 28 | CSNK1A1L | 1.68491422 |
| 29 | MAPKAPK5 | 1.66214199 |
| 30 | TNK2 | 1.65413856 |
| 31 | FES | 1.64659687 |
| 32 | FGFR2 | 1.63914727 |
| 33 | CLK1 | 1.59988939 |
| 34 | CSNK1G1 | 1.58218781 |
| 35 | FGR | 1.56329330 |
| 36 | PNCK | 1.53842824 |
| 37 | MAPK12 | 1.53341167 |
| 38 | LIMK1 | 1.49971696 |
| 39 | TXK | 1.45290372 |
| 40 | BCKDK | 1.45144426 |
| 41 | UHMK1 | 1.35369252 |
| 42 | TYK2 | 1.33933792 |
| 43 | TESK2 | 1.32109509 |
| 44 | PRPF4B | 1.31006148 |
| 45 | ROCK2 | 1.29659545 |
| 46 | HCK | 1.28674472 |
| 47 | CSNK1G2 | 1.28549636 |
| 48 | MUSK | 1.24173128 |
| 49 | PAK6 | 1.22080501 |
| 50 | PDGFRB | 1.20767702 |
| 51 | ITK | 1.20356594 |
| 52 | CSK | 1.18549300 |
| 53 | MAP3K7 | 1.18128420 |
| 54 | IRAK2 | 1.17329976 |
| 55 | CASK | 1.13963139 |
| 56 | MAP3K11 | 1.10010186 |
| 57 | MAP2K6 | 1.04618983 |
| 58 | CAMK2B | 1.03830486 |
| 59 | DYRK2 | 0.99189350 |
| 60 | JAK1 | 0.95960613 |
| 61 | NLK | 0.91825380 |
| 62 | MARK2 | 0.89940629 |
| 63 | PINK1 | 0.89437577 |
| 64 | TBK1 | 0.88406679 |
| 65 | IRAK1 | 0.88286044 |
| 66 | PASK | 0.88008433 |
| 67 | CAMKK2 | 0.87514834 |
| 68 | SCYL2 | 0.86342870 |
| 69 | PIM1 | 0.86221626 |
| 70 | CAMK2D | 0.85509110 |
| 71 | MAPK11 | 0.79105060 |
| 72 | BLK | 0.77800679 |
| 73 | NTRK1 | 0.77416397 |
| 74 | JAK2 | 0.73161422 |
| 75 | * PRKCQ | 0.71068558 |
| 76 | IRAK4 | 0.71054660 |
| 77 | SGK223 | 0.70426800 |
| 78 | SGK494 | 0.70426800 |
| 79 | PAK3 | 0.69233595 |
| 80 | MAP4K1 | 0.68889263 |
| 81 | FGFR3 | 0.67726442 |
| 82 | MAP3K14 | 0.67205401 |
| 83 | MAP3K1 | 0.66642020 |
| 84 | TRPM7 | 0.66629065 |
| 85 | * LCK | 0.66576839 |
| 86 | MAPK13 | 0.64634009 |
| 87 | ERBB4 | 0.63846702 |
| 88 | IKBKB | 0.62623644 |
| 89 | FYN | 0.61104789 |
| 90 | CAMK2G | 0.60593335 |
| 91 | ADRBK2 | 0.60354031 |
| 92 | PDK1 | 0.59728088 |
| 93 | BMPR1B | 0.59228658 |
| 94 | OBSCN | 0.59175378 |
| 95 | RPS6KA5 | 0.58530623 |
| 96 | PHKG1 | 0.57160413 |
| 97 | PHKG2 | 0.57160413 |
| 98 | MAPK7 | 0.56422871 |
| 99 | CAMK2A | 0.56221481 |
| 100 | MARK3 | 0.55745798 |
| 101 | CSNK1D | 0.50172520 |
| 102 | KIT | 0.49929701 |
| 103 | CDK14 | 0.49344482 |
| 104 | MAPK15 | 0.48721684 |
| 105 | TAOK2 | 0.47481816 |
| 106 | PRKCH | 0.47206348 |
| 107 | CDK5 | 0.46670236 |
| 108 | SGK2 | 0.45249823 |
| 109 | HIPK2 | 0.45062508 |
| 110 | MARK1 | 0.44924074 |
| 111 | SIK3 | 0.44874371 |
| 112 | INSR | 0.44675610 |
| 113 | RAF1 | 0.44583535 |
| 114 | NME1 | 0.42054244 |
| 115 | EPHA4 | 0.41829454 |
| 116 | PDPK1 | 0.41567175 |
| 117 | NUAK1 | 0.41434511 |
| 118 | PRKG1 | 0.41303020 |
| 119 | SGK3 | 0.41293358 |
| 120 | CDK4 | 0.41123219 |
| 121 | MAP3K3 | 0.40998641 |
| 122 | CDK3 | 0.40931228 |
| 123 | CSNK1A1 | 0.40741125 |
| 124 | IKBKE | 0.40712979 |
| 125 | MAP2K4 | 0.39868926 |
| 126 | PRKD1 | 0.39809044 |
| 127 | MELK | 0.39778266 |
| 128 | CDK15 | 0.39690641 |
| 129 | CDK11A | 0.39541896 |
| 130 | DYRK1B | 0.38876216 |
| 131 | MAP3K13 | 0.38285022 |
| 132 | STK10 | 0.36361482 |
| 133 | MAPKAPK3 | 0.35724332 |
| 134 | CAMK1G | 0.35342712 |
| 135 | GSK3A | 0.35224402 |
| 136 | BRD4 | 0.34803921 |
| 137 | CDK18 | 0.34467834 |
| 138 | STK16 | 0.34171618 |
| 139 | RPS6KA4 | 0.34115347 |
| 140 | LYN | 0.33170874 |
| 141 | CSF1R | 0.33028439 |
| 142 | CAMK4 | 0.32848272 |
| 143 | VRK2 | 0.32260385 |
| 144 | DYRK1A | 0.32232007 |
| 145 | PRKCE | 0.32026527 |
| 146 | MKNK1 | 0.30128965 |
| 147 | CAMKK1 | 0.29712934 |
| 148 | MAP3K10 | 0.29669064 |
| 149 | PRKD2 | 0.29187832 |
| 150 | PTK2B | 0.28055514 |
| 151 | PIK3CA | 0.27463325 |
| 152 | MAPK4 | 0.27438478 |
| 153 | JAK3 | 0.27111263 |
| 154 | RPS6KC1 | 0.26926148 |
| 155 | RPS6KL1 | 0.26926148 |
| 156 | MAP3K5 | 0.26511907 |
| 157 | RPS6KB2 | 0.25505938 |
| 158 | GRK7 | 0.25432585 |
| 159 | RPS6KA6 | 0.25185312 |
| 160 | MAPK3 | 0.24938925 |
| 161 | PRKAA2 | 0.24359181 |
| 162 | STK11 | 0.23854905 |
| 163 | RPS6KB1 | 0.21521450 |
| 164 | CAMK1 | 0.20942935 |
| 165 | SGK1 | 0.18032955 |
| 166 | CDK12 | 0.17990194 |
| 167 | RPS6KA1 | 0.17435648 |
| 168 | LRRK2 | 0.17059272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.68743145 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.26836025 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.08976705 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.66682580 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.62018565 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.06153542 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.25841891 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.19434920 |
| 9 | * Measles_Homo sapiens_hsa05162 | 2.12479579 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01493902 |
| 11 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.98573679 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 1.87490547 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85333202 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.83892203 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.81979872 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75442637 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72386125 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71910777 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71594518 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.69761527 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.68304214 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.65425586 |
| 23 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62578084 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.60939239 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57242116 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55484798 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51139995 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47629744 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46245346 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44126449 |
| 31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35491956 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33744532 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33056595 |
| 34 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31620223 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24230807 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23802345 |
| 37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.23768475 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21961269 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16532770 |
| 40 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.12093649 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10948455 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07101687 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03757846 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03359015 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03267985 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03164859 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.02207443 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01869881 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99681595 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98869380 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96423281 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96384556 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96316866 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95810758 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93025342 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90723112 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90183732 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89077775 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89036790 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88658291 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87623608 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87018019 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86513980 |
| 64 | * Insulin resistance_Homo sapiens_hsa04931 | 0.85880521 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.84431622 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.83764114 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82778625 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80937110 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.80927011 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80689518 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80618411 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78985946 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.78637691 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.78004252 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77663405 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77431351 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76300351 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.76270196 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75525880 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75180435 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74230183 |
| 82 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73464701 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72781377 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71666424 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71268785 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.71244554 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70106575 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.68818998 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68014796 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.66955164 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66763997 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65520197 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.64646123 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64286983 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63366885 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63319446 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62461306 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.60835474 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60748310 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56886632 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56304778 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56035926 |
| 103 | Ribosome_Homo sapiens_hsa03010 | 0.55626054 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55525035 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54501248 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54396530 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.53311941 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53159076 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.52522222 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51692142 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51375537 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51341924 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51313137 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.50433918 |
| 115 | * Tight junction_Homo sapiens_hsa04530 | 0.50410310 |
| 116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50312181 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49842632 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48818651 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.48355829 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47755762 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47330145 |
| 122 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47103123 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46888625 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46641063 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45731290 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44544538 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44542842 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44213380 |
| 129 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44091806 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43216699 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42719640 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42109227 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41852764 |
| 134 | Morphine addiction_Homo sapiens_hsa05032 | 0.41307502 |
| 135 | RNA degradation_Homo sapiens_hsa03018 | 0.41067642 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40747905 |
| 137 | Prostate cancer_Homo sapiens_hsa05215 | 0.39426977 |
| 138 | Proteasome_Homo sapiens_hsa03050 | 0.38969280 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38491250 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38087266 |
| 141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37290310 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37228539 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37036928 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.36609893 |
| 145 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35130689 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34699013 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34232092 |
| 148 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34221501 |
| 149 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33181390 |
| 150 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32656083 |
| 151 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31931136 |
| 152 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31462954 |
| 153 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30799597 |
| 154 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30403648 |
| 155 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30065663 |
| 156 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29227816 |
| 157 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28984366 |
| 158 | Platelet activation_Homo sapiens_hsa04611 | 0.27698845 |
| 159 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25585550 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.25443775 |
| 161 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.23312476 |
| 162 | Lysosome_Homo sapiens_hsa04142 | 0.21607613 |
| 163 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20929855 |
| 164 | Hepatitis C_Homo sapiens_hsa05160 | 0.20891185 |
| 165 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20369735 |
| 166 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20297355 |
| 167 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20095696 |
| 168 | Salivary secretion_Homo sapiens_hsa04970 | 0.19850173 |

